This narrative review looks at endothelial ferroptosis in the context of ischemic stroke, neurodegenerative conditions, and inflammatory conditions. The study focused on brain microvascular endothelial cells rather than people. No specific medications or patient groups were tested in this analysis. The authors note that current models are limited to cell lines and do not fully represent human biology.
The review highlights several areas where more research is needed. Scientists state that models specific to brain microvascular endothelial cells are required to better understand these processes. Human blood-brain barrier systems also need to be studied to see how these cells behave in real bodies. Additionally, biomarkers that can detect endothelial ferroptosis are currently missing from the field.
There are important safety concerns that must be addressed before any treatment can be considered. The physiological risks of blocking ferroptosis systemically or for prolonged periods need careful evaluation. Delivery approaches that specifically target these brain cells also require further testing. Until these gaps are filled, the practical relevance of these findings for patient care remains unclear.